Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Issues of Peribulbar Injection of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) in Patients With Retinitis Pigmentosa

NCT04315025 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.

NCT NCT04315025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Issues of Peribulbar Injection of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) in Patients With Retinitis Pigmentosa
Lead sponsor
PT. Prodia Stem Cell Indonesia
Phase
Phase 1/2
Overall status
Completed
Start date
October 7, 2018
Completion date
September 20, 2019
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa